Eden Research (LON:EDEN) Stock Price Down 3.3% – What’s Next?

Shares of Eden Research plc (LON:EDEN) fell 3.3% during trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The firm has a fifty day simple moving average of GBX 3.87 and a 200 day simple moving average of GBX 3.95. The company has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92.

Insider Transactions at Eden Research

In related news, insider Lykele van der Broek acquired 256,000 shares of the stock in a transaction dated Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,958.74). Also, insider Alexander John Abrey acquired 540,540 shares of the stock in a transaction dated Tuesday, January 28th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,362.19). 14.02% of the stock is currently owned by corporate insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.